Ce site utilise des cookies comme décrit dans notre cookie policy. Pour voir quels cookies nous utilisons, veuillez consulter notre Panneau de configuration des cookies. Je suis d'accord avec cette politique de cookies, ne plus afficher ce message

Event on

Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease

Présentations

  • PROF. GOTTFRIED RUDOFSKY

    PROF. GOTTFRIED RUDOFSKY
    (SWITZERLAND)
    Speaker

    Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland

Les points de vues et opinions présentés n’engagent que les orateurs. Le contenu de ce webcast est destiné à des fins informatives / éducatives uniquement.

CONTEXTE

Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether1 — which is why testing in at-risk groups is so important.

Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it valtogether.

Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Series of six livestream events covering:

  • Importance of regular testing for early detection and monitoring in high-risk patients
  • Importance of ACR testing beside the determination of eGFR
  • Latest guidance on disease prevention and management
  • Case studies
Share
Like
Tweet
References
  1. Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
  2. The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease.%20Accessed%201.%20September%202022 https://www.worldkidneyday.org/facts/chronic-kidney-disease. Accessed 1. September 2022

© 2023 Abbott. Tous les droits sont réservés. Toutes les marques commerciales référencées sont des marques commerciales du groupe de sociétés Abbott ou de leurs propriétaires respectifs. COL-00000

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"fr","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"fr","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/fr/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"fr","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/fr/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/fr/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Bugsnag Called"